GLUTAMATE NMDA RECEPTORS IN EPILEPTIC CORTEX
GLUTAMATE NMDA RECEPTORS IN EPILEPTIC CORTEX
批准号:
2902343
负责人:
THOMAS L. BABB
金额:
$23.28万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-08-01 至 2002-06-30
关键词:
NMDA receptors biopsy brain electrical activity cerebellar cortex clinical research confocal scanning microscopy electrophysiology epilepsy generalized seizures glutamates histopathology human subject human tissue immunocytochemistry immunoprecipitation in situ hybridization neurons neuropharmacology neurophysiology northern blottings receptor expression voltage /patch clamp
中文摘要
描述:(逐字从申请人的摘要)这个项目的目的是
确定和量化NMDA受体蛋白的分子机制,
它们的亚基共组装体是必要的和/或足够的,
生理学证实癫痫患者大脑皮层兴奋性
癫痫发作最常见的耐药新皮质癫痫发作发生在人类
皮质发育不良的癫痫患者。这种严重的癫痫病发生在
约20%的癫痫患者,并与最严重的
与其他焦点或广义相比,
癫痫大多数皮质发育不良可以通过手术切除,
在某些情况下,缉获量减少或消除。然而,手术成功不能
根据切除皮质的常规组织病理学分析预测。
约50%的病例发生需要药物治疗的持续癫痫发作。通过
相比之下,NMDA受体的复杂免疫细胞化学现在已经揭示了
NR 2亚基的上调,以及它们与NR 1亚基的共表达,
癫痫性而非非癫痫性皮质。该提案旨在揭示
通过检查NMDA受体产生超兴奋性的机制,
新鲜切除的癫痫皮质(通过术前皮质检查记录)
EEG癫痫发作的记录)。定量比较将在
每个患者的“癫痫”和“非癫痫”皮质(没有EEG发作)。
这些平行研究将揭示NMDA受体组成的差异
和功能:1)NMDA受体蛋白亚基基因产物NR 2A、B和
它们与NR 1 A-H的共组装体)剪接变体); 2)双标记的NR 1-NR 2
单个发育不良神经元的免疫荧光; 3)免疫共沉淀印迹
对于NR 1-NR 2抗体; 4)北方印迹(用mRNA杂交试验,
NR 2 A、B和NR 1剪接变体A-H; 5)定量原位杂交,
确定北方印迹mRNA; 6)体外切片和分离的神经元
场电位电生理学、膜片钳记录和选择性
NMDA受体亚单位的药理学阻断。这些多学科
蛋白质、分子和药物生理学分析将提供新的
关于癫痫机制的信息,并可能提出新的方法
到设计新药这些药物应选择性地作用于高兴奋性
具有独特的NR 2和NR 1异聚体共组装体的发育不良神经元
亚单位没有发现“非癫痫”皮质神经元。具体
受体靶向药物将避免一般神经系统抑郁症,
应提供更有效的管理癫痫皮质发育不良。
英文摘要
DESCRIPTION: (Verbatim from the Applicant's Abstract) This project is designed
to identify and quantify the molecular mechanisms of NMDA receptor proteins and
their subunit coassemblies that are necessary and/or sufficient for
hyperexcitability of physiologically-verified (EEG) epileptic human cortical
seizures. The most frequent drug-resistant neocortical seizures occur in human
epileptics with cortical dysplasia. This serious seizure disorder occurs in
approximately 20% OF all epileptics and is associated with the most severe
social and educational retardations compared to the other focal or generalized
epilepsies. Most of these cortical dysplasias can be surgically removed and in
some cases seizures are reduced or eliminated. Surgical success however cannot
be predicted from routine histopathologic analysis of the resected cortex.
Continued seizures requiring medication occur in about 50% of cases. By
contrast, sophisticated immunocytochemistry on NMDA receptors has now revealed
upregulation of the NR2 subunits, and their coexpression with NR1 subunits in
epileptic but not non-epileptic cortex. This proposal is designed to uncover
the mechanisms by which NMDA receptors generate hyperexcitability by examining
freshly resected epileptic cortex (documented by preoperative cortical
recordings of the EEG seizure onset). Quantitative comparisons will be made in
each patient's "epileptic" and "non-epileptic" cortex (no EEG seizure onsets).
These parallel studies will uncover differences in NMDA receptor composition
and function in: 1) NMDA receptor protein subunit gene products NR2A, B and
their coassemblies with NR1 A-H )splice variants); 2) double-labeled NR1-NR2
immunofluorescence on single dysplastic neurons; 3) coimmunoprecipitation blots
for NR1-NR2 antibodies; 4) Northern blots (with mRNA hybridization tests for
NR2A, B, and NR1 splice variants A-H; 5) quantitative in situ hybridization to
confirm Northern blot mRNAs; and 6) in vitro slice and dissociated neuron
electrophysiology with field potential, patch clamp recordings, and selective
pharmacologic blockade of NMDA receptor subunits. These multidisciplinary
protein, molecular, and pharmaco-physiologic analyses will provide new
information about the mechanisms of epilepsy and may suggest novel approaches
to designing new drugs. These drugs should selectively act on hyperexcitable
dysplastic neurons that have unique heteromeric coassemblies of NR2 and NR1
subunits not found on "non-epileptic" cortical neurons. Specific
receptor-targeted drugs would avoid general nervous system depression and
should provide more effective management of epilepsy in cortical dysplasia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of NMDA Synapses in Rat Dysplastic Neurons
-
批准号:6875672
-
项目类别:
-
资助金额:$31.85万
-
财政年份:2002
-
负责人:THOMAS L. BABB
-
依托单位:
Development of NMDA Synapses in Rat Dysplastic Neurons
-
批准号:6471478
-
项目类别:
-
资助金额:$31.85万
-
财政年份:2002
-
负责人:THOMAS L. BABB
-
依托单位:
Development of NMDA Synapses in Rat Dysplastic Neurons
-
批准号:6723656
-
项目类别:
-
资助金额:$31.85万
-
财政年份:2002
-
负责人:THOMAS L. BABB
-
依托单位:
Development of NMDA Synapses in Rat Dysplastic Neurons
-
批准号:6623957
-
项目类别:
-
资助金额:$31.85万
-
财政年份:2002
-
负责人:THOMAS L. BABB
-
依托单位:
GLUTAMATE NMDA RECEPTORS IN EPILEPTIC CORTEX
-
批准号:6454654
-
项目类别:
-
资助金额:$20.02万
-
财政年份:1999
-
负责人:THOMAS L. BABB
-
依托单位:
GLUTAMATE NMDA RECEPTORS IN EPILEPTIC CORTEX
-
批准号:6394041
-
项目类别:
-
资助金额:$24.98万
-
财政年份:1999
-
负责人:THOMAS L. BABB
-
依托单位:
MICROANATOMY OF HUMAN EPILEPTIC HIPPOCAMPAL FORMATION
-
批准号:6204966
-
项目类别:
-
资助金额:$24.81万
-
财政年份:1999
-
负责人:THOMAS L. BABB
-
依托单位:
GLUTAMATE NMDA RECEPTORS IN EPILEPTIC CORTEX
-
批准号:6188028
-
项目类别:
-
资助金额:$3.58万
-
财政年份:1999
-
负责人:THOMAS L. BABB
-
依托单位:
MICROANATOMY OF HUMAN EPILEPTIC HIPPOCAMPAL FORMATION
-
批准号:6111873
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:THOMAS L. BABB
-
依托单位:
MICROANATOMY OF HUMAN EPILEPTIC HIPPOCAMPAL FORMATION
-
批准号:6243357
-
项目类别:
-
资助金额:$18.1万
-
财政年份:1997
-
负责人:THOMAS L. BABB
-
依托单位:
NEUROBIOLOGY AND PATHOGENESIS OF HIPPOCAMPAL EPILEPSY
-
批准号:2269602
-
项目类别:
-
资助金额:$21.38万
-
财政年份:1995
-
负责人:THOMAS L. BABB
-
依托单位:
NEUROBIOLOGY AND PATHOGENESIS OF HIPPOCAMPAL EPILEPSY
-
批准号:2269600
-
项目类别:
-
资助金额:$27.69万
-
财政年份:1994
-
负责人:THOMAS L. BABB
-
依托单位:
NEUROBIOLOGY AND PATHOGENESIS OF HIPPOCAMPAL EPILEPSY
-
批准号:2269601
-
项目类别:
-
资助金额:$7.03万
-
财政年份:1994
-
负责人:THOMAS L. BABB
-
依托单位:
NEUROBIOLOGY AND PATHOGENESIS OF HIPPOCAMPAL EPILEPSY
-
批准号:2269603
-
项目类别:
-
资助金额:$28.35万
-
财政年份:1994
-
负责人:THOMAS L. BABB
-
依托单位:
NEUROBIOLOGY AND PATHOGENESIS OF HIPPOCAMPAL EPILEPSY
-
批准号:2379680
-
项目类别:
-
资助金额:$29.48万
-
财政年份:1994
-
负责人:THOMAS L. BABB
-
依托单位:
MICROANATOMY OF HUMAN EPILEPTIC HIPPOCAMPAL FORMATION
-
批准号:5214977
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:THOMAS L. BABB
-
依托单位:--
海外基金